Innate Pharma S.A. (EPA:IPH)
France · Delayed Price · Currency is EUR 1.406
-0.040 (-2.77%)
Feb 20, 2026, 5:35 PM CET
Innate Pharma Market Cap
Innate Pharma has a market cap or net worth of €131.78 million as of February 20, 2026. Its market cap has decreased by -17.25% in one year.
Market Cap
131.78M
Enterprise Value
98.78M
Revenue
12.64M
Ranking
n/a
PE Ratio
n/a
Stock Price
€1.41
Market Cap Chart
Since November 1, 2006, Innate Pharma's market cap has increased from 792.12K to 131.78M, an increase of 16,535.97%. That is a compound annual growth rate of 30.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 20, 2026 | 131.78M | -10.76% |
| Dec 31, 2025 | 147.67M | -7.67% |
| Dec 31, 2024 | 159.94M | -24.29% |
| Dec 29, 2023 | 211.24M | -19.93% |
| Dec 30, 2022 | 263.84M | -24.98% |
| Dec 31, 2021 | 351.67M | 28.64% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Genfit | 392.39M |
| Cellectis | 248.80M |
| Transgene | 225.09M |
| MaaT Pharma | 138.87M |
| Adocia | 137.15M |
| ABIONYX Pharma | 118.36M |
| OSE Immunotherapeutics | 96.41M |
| Sensorion | 94.91M |